Page last updated: 2024-10-29

ifosfamide and Genetic Predisposition

ifosfamide has been researched along with Genetic Predisposition in 2 studies

Research Excerpts

ExcerptRelevanceReference
" The male patient was enrolled into the research programme for the evaluation of the association between deletion of the genes encoding a number of classes of glutathione S-transferases (GST) and adverse reactions to alkylating agents."5.31Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathione S-transferases GSTM1 and GSTT1. ( Bodalski, J; Zielińska, E, 2001)
"Ifosfamide (IFA) is a potent alkylating antitumoral agent, but its use is limited by neurological side effects."1.48Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases. ( Bellien, J; Duflot, T; Filhon, B; Joannidès, R; Lamoureux, F; Marie-Cardine, A; Massy-Guillemant, N; Pereira, T; Verstuyft, C, 2018)
" The male patient was enrolled into the research programme for the evaluation of the association between deletion of the genes encoding a number of classes of glutathione S-transferases (GST) and adverse reactions to alkylating agents."1.31Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathione S-transferases GSTM1 and GSTT1. ( Bodalski, J; Zielińska, E, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duflot, T1
Marie-Cardine, A1
Verstuyft, C1
Filhon, B1
Pereira, T1
Massy-Guillemant, N1
Joannidès, R1
Bellien, J1
Lamoureux, F1
Zielińska, E1
Bodalski, J1

Other Studies

2 other studies available for ifosfamide and Genetic Predisposition

ArticleYear
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
    Fundamental & clinical pharmacology, 2018, Volume: 32, Issue:3

    Topics: Administration, Intravenous; Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Di

2018
Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathione S-transferases GSTM1 and GSTT1.
    Cytobios, 2001, Volume: 106, Issue:413

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool;

2001